Announced
SOBI to acquire Pint Pharma International from Farallon Capital-backed Pintador.
Synopsis
SOBI, a biopharmaceutical and biotechnology company, agreed to acquire Pint Pharma International, a biopharmaceutical company, from Farallon Capital-backed Pintador, a holding company. Financial terms were not disclosed.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite